University of Texas at Austin
426
66
88
212
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.5%
32 terminated/withdrawn out of 426 trials
86.9%
+0.4% vs industry average
5%
20 trials in Phase 3/4
17%
36 of 212 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (426)
Rebreathing-induced Hypoxia and Glucose Levels
Role: lead
A Feasibility Study for Randomization of Code Stroke Imaging Strategies
Role: lead
Mother Infant Nutrition Study
Role: lead
Invasive Brain-Computer Interfaces for Attention
Role: lead
Non-invasive BCI-controlled Assistive Devices
Role: lead
Psychotherapy Effects on Reward Processing in PTSD
Role: lead
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
Role: lead
Malaria CVD 36000; Gates INV090205
Role: collaborator
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
Role: lead
Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
Role: lead
Focused Ultrasound Amygdala Neuromodulation
Role: lead
Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19
Role: lead
Mothers And careGivers Investing in Children
Role: lead
Usability of the Regen Gait Therapy Robot in Healthy Adults
Role: lead
Testing FIRST in Youth Outpatient Psychotherapy
Role: collaborator
Shaping Habitual Impulses For a Tobacco-free Style
Role: collaborator
Suzetrigine for Opioid-Free Recovery After Cesarean Delivery
Role: lead
Intervention for Hearing Health Among Native Americans
Role: collaborator
Approach-Avoidance and Alcohol Challenge Study in PTSD
Role: lead
Development of MENU Protocol
Role: lead